DLA Piper LLP (US)

Drawing upon lawyers with ‘first-hand medical practice experience and highly technical expertise’, DLA Piper LLP (US) combines strong procedural nous with deep subject matter knowledge, in turn being well positioned to represent life sciences clients on work throughout the litigation life cycle. As well as regularly acting as national co-ordinating counsel on large-scale domestic MDLs, the team regularly works alongside practitioners throughout its global network of offices on cross-border work, and is recognized for its ’excellent‘ work in co-ordinating multinational law suits. In this context, ’outstanding’ Atlanta-based Christopher Campbell continues to take the lead for Bayer on global mass tort litigation involving Essure, leveraging the knowledge and skills gleaned from the firm’s success in the initial US action to good effect on the ensuing international cases. Praised for her ‘ability to see the big picture’, as well as her ’highly impressive knowledge of the medical facts’, Mary Gately in Washington DC has also been key to the firm’s success for Bayer. New York-based Loren Brown is well-versed in handling large-scale aggregated litigation, including his ongoing work as co-national counsel for Sanofi in the Zantac MDL; where he has gained an excellent reputation for securing the early dismissal of matters through often innovative strategies. From Boston, Matthew Holian is also very effective at representing pharmaceutical companies engaged in MDLs, being as comfortable handling discovery issues, as he is cross-examining expert witnesses in Daubert hearings and in bellwether trials. Other key individuals include Dallas-based trial lawyer Lyn Pruitt; Boston-based Katie Insogna, who excels at developing expert witnesses and on discovery matters; and New York based Lucas Przymusinski , who ‘has an incredibly scientific mind in addition to legal expertise’.